GPT and metabolic dysfunction-associated steatotic liver disease: Physicians are often reluctant to use statins in patients with NAFLD, but many studies indicate that they could have a beneficial effect by reducing cardiovascular disease mortality and alleviating liver damage, as indicated by decreases in ALT, AST and gamma-glutamyl transferase (GGT) serum levels [55].